| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $12,031,798 ) (Continued on the next page) |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $79,136 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM162501 | Dissecting a Novel Pathway for Degradative Endosome Generation during Rapid Synaptic Vesicle Recycling Pathway | 000 | 1 | NIH | 2/10/2026 | $462,500 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 000 | 2 | NIH | 1/15/2026 | $416,250 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 000 | 2 | NIH | 1/14/2026 | $608,750 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS100939 | Sonic Hedgehog Signaling in Neocortical Growth and Folding | 000 | 8 | NIH | 1/14/2026 | $513,534 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH139498 | Thalamocortical disruption as a convergence point for schizophrenia risks | 000 | 2 | NIH | 2/11/2026 | $662,341 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY037117 | The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | 000 | 2 | NIH | 1/30/2026 | $606,034 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 000 | 5 | NIH | 1/9/2026 | $343,981 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 000 | 2 | NIH | 12/23/2025 | $645,099 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 000 | 2 | NIH | 12/23/2025 | $627,177 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 000 | 14 | NIH | 1/27/2026 | $405,403 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA259581 | Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia | 000 | 6 | NIH | 12/12/2025 | $433,868 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA270785 | Mapping the Cerebellar Origins of Medulloblastoma Subgroups | 000 | 4 | NIH | 1/22/2026 | $617,419 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG093113 | Novel pro-drug imaging agents to detect neuroinflammation in Alzheimer's Disease | 000 | 1 | NIH | 1/21/2026 | $758,781 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI099394 | Mechanistic Studies Of The Staphylococcus aureus LukAB Cytotoxin | 000 | 12 | NIH | 12/29/2025 | $637,453 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 5 | NIH | 12/31/2025 | $502,279 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA266935 | IMPROVING PROGNOSTIC COMMUNICATION IN PEDIATRIC CANCER | 000 | 4 | NIH | 12/10/2025 | $226,876 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA279926 | Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth” | 000 | 3 | NIH | 12/22/2025 | $237,400 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 000 | 32 | NIH | 2/10/2026 | $3,984,912 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $366,056 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM141947 | Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs | 000 | 5 | NIH | 11/6/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 000 | 41 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA280230 | Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors | 000 | 2 | NIH | 10/7/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA280187 | Caregiver Education with Interactive Neurodevelopmental Games to Improve Cognitive and Social-Emotional Outcomes in Infants Undergoing Treatment for Medulloblastoma | 000 | 2 | NIH | 1/6/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | 000 | 5 | NIH | 11/10/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS122394 | Structural Basis of Signal Instigation Through Family C GPCRs | 000 | 6 | NIH | 12/23/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS123116 | Interneuron circuits in the spinal motor system | 000 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 000 | 5 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA279520 | Trajectory of epigenetic aging and health outcomes in childhood cancer survivors | 000 | 2 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290112 | Genomics-based Mechanistic Investigation of Cancer-treatment Related Cardiotoxicity among Survivors of Childhood Cancer | 000 | 2 | NIH | 1/26/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 000 | 21 | NIH | 11/6/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA245301 | Regulation of collagen linearization during cancer progression and metastasis | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA251436 | Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma | 000 | 5 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA241452 | Pathogenesis of ETV6-Related Acute Lymphoblastic Leukemia | 000 | 4 | NIH | 1/6/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA262589 | Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors | 000 | 4 | NIH | 1/20/2026 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI136514 | DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHC | 001 | 8 | NIH | 2/2/2026 | -$799,765 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA255569 | WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor | 000 | 5 | NIH | 11/19/2025 | $0 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA300913 | Hypofractionated radiation in combination with B7-H3-CAR T cells for pediatric patients with relapsed/refractory sarcomas | 000 | 1 | NIH | 12/11/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA246570 | Telehealth based exercise intervention to improve functional capacity in survivors of childhood cancer with significantly limited exercise tolerance | 000 | 3 | NIH | 12/22/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA195547 | The St. Jude Lifetime Cohort | 000 | 10 | NIH | 11/21/2025 | -$1,085 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS097974 | Dynamic RNA-protein assemblies and neurological disease | 000 | 8 | NIH | 12/5/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS119760 | Understanding the developmental progression of subpallial neural progenitor cells | 000 | 4 | NIH | 12/3/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA193651 | Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias | 000 | 11 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG068581 | Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis | 000 | 2 | NIH | 1/22/2026 | -$29,018 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI157312 | Spectinomycin analogs for NTM infections | 000 | 5 | NIH | 1/30/2026 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99CA283256 | Functional and Pharmacologic Investigation of the NUP98 Fusion Oncoprotein Interactome | 000 | 2 | NIH | 11/17/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99DK135910 | Elucidating function of disease-related SAMD9L mutations in hematopoiesis | 000 | 2 | NIH | 2/12/2026 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA245251 | Targeting EP300, a selective dependency in neuroblastoma | 000 | 5 | NIH | 12/18/2025 | -$3,831 |
| | 2026 | 2023 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA261713 | PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention | 000 | 2 | NIH | 11/19/2025 | $0 |
|
